Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01630733
Title A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors OncoGenex Technologies
Indications
Therapies
Age Groups: adult
Covered Countries USA | POL | NZL | ITA | ISR | HUN | ESP | DEU | AUS


No variant requirements are available.